We performed immunohistochemistry and immunofluorescence staining to determine vimentin+, c-kit/CD117+ and CD34+ TCs in EMT-6/stromal cells reconstituted breast cancer tissue (Fig. 5). This evidence concerns the gene VIM and breast cancer.